Back to Journals » ClinicoEconomics and Outcomes Research » Volume 8

Cost-effectiveness of edoxaban versus rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) in the US

Total article views   HTML views PDF downloads Totals
22,960 Dovepress* 12,703+ 2,211 14,914
PubMed Central* 10,257 890 11,147
Totals 22,960 3,101 26,061
*Since 20 May 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 3 5

View citations on PubMed Central and Google Scholar